期刊
EMERGING INFECTIOUS DISEASES
卷 27, 期 5, 页码 1472-1476出版社
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2705.204056
关键词
-
资金
- National Institutes of Health, USA [PO1 AI060699]
- National Science and Technology Project [81772191]
The study of antibody responses in MERS-CoV infection survivors in Saudi Arabia showed the presence of specific neutralizing antibodies up to 6 years postinfection. This finding provides crucial information for the development of MERS-CoV vaccines.
Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV specific neutralizing antibodies were detected for 6 years postinfection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据